We are live on ! Find out more
WINT

Windtree Therapeutics Inc

Delisted

WINT was delisted on the 4th of May, 2017.

33 hedge funds and large institutions have $8M invested in Windtree Therapeutics Inc in 2016 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 13 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

992% more call options, than puts

Call options by funds: $688K | Put options by funds: $63K

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

22% more capital invested

Capital invested by funds: $6.57M → $8M (+$1.42M)

0% more funds holding

Funds holding: 3333 (0)

77% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 13

Holders
33
Holders Change
Holders Change %
0%
% of All Funds
0.88%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
3
Reduced
13
Closed
1
Calls
$688K
Puts
$63K
Net Calls
+$625K
Net Calls Change
+$117K
Name Holding Trade Value Shares
Change
Change in
Stake
RFS
26
Rockefeller Financial Services
New York
-$53K -27,658 Closed
Wells Fargo
27
Wells Fargo
California
-$1.38K -634 -90%

WINT Hedge Fund Activity: Q3 2016 in Review

33 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Windtree Therapeutics Inc (WINT) for Q3 2016, worth a combined $8M — up 22% from $6.57M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new WINT positions and 1 closed out — a net gain of 1 holder — while 3 added to existing stakes and 13 trimmed.

The largest buyer was Summit Financial Wealth Advisors, opening a new position worth an estimated $28.3K. The largest seller was Sabby Management, cutting an estimated $301K.

  • 33 institutional investors held Windtree Therapeutics Inc (WINT) as of Q3 2016, unchanged from Q2 2016.
  • Funds reported $8M of Windtree Therapeutics Inc stock for Q3 2016, up 22% quarter-over-quarter.
  • 2 funds opened new Windtree Therapeutics Inc positions in Q3 2016 and 1 closed out, a net change of +1 holder.
  • The largest Windtree Therapeutics Inc buyer in Q3 2016 was Summit Financial Wealth Advisors, an estimated $28.3K added.
  • The largest Windtree Therapeutics Inc seller in Q3 2016 was Sabby Management, an estimated $301K sold.

Based on aggregated 13F filings for Q3 2016.